ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

MDGL Madrigal Pharmaceuticals Inc

276.40
-0.32 (-0.12%)
2024年6月19日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Madrigal Pharmaceuticals Inc MDGL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.32 -0.12% 276.40 09:00:00
始値 安値 高値 終値 前日終値
276.88 273.28 279.26 276.01 276.72
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1910:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1510:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1506:17EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1505:37EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1406:53EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1306:03EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1206:39EDGAR2Form 144 - Report of proposed sale of securities
2024/6/0707:48EDGAR2Form 144 - Report of proposed sale of securities
2024/6/0621:00GLOBEMadrigal Pharmaceuticals Announces New Data from the Phase 3..
2024/6/0521:00GLOBEMadrigal Pharmaceuticals to Participate in the Goldman Sachs..
2024/5/2921:00GLOBEMadrigal Pharmaceuticals to Present Multiple Rezdiffra™..
2024/5/2410:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0805:36EDGAR2Form 8-K - Current report
2024/5/0805:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0805:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/0722:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0720:06EDGAR2Form 8-K - Current report
2024/5/0720:00GLOBEMadrigal Pharmaceuticals Reports First-Quarter 2024..
2024/4/2505:00GLOBEMadrigal Statement on the Passing of Dr. Stephen Harrison
2024/4/2321:00GLOBEMadrigal Pharmaceuticals to Release First-Quarter 2024..
2024/4/1705:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
2024/4/0921:00GLOBEMadrigal Pharmaceuticals Announces U.S. Availability of..
2024/4/0405:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
2024/3/1912:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Upsized $600..
2024/3/1905:04GLOBEMadrigal Pharmaceuticals Announces Proposed Public Offering
2024/3/1520:30IHMARKETNEWSAdobe Stock Drops Following Below-Estimate Projections,..
2024/3/1505:15GLOBEMadrigal Pharmaceuticals Announces FDA Approval of..
2024/3/0706:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
2024/3/0522:00GLOBEMadrigal Pharmaceuticals Announces EMA Validation of its..
2024/2/2821:10EDGAR2Form 8-K - Current report
2024/2/2821:01EDGAR2Form 8-K - Current report
2024/2/2821:01GLOBEMadrigal Pharmaceuticals Appoints Mardi C. Dier as Chief..
2024/2/2821:00GLOBEMadrigal Pharmaceuticals Provides Corporate Updates and..
2024/2/2820:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2122:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
2024/2/1504:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1423:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1407:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:00GLOBEMadrigal Pharmaceuticals Announces Publication of the Phase..
2024/2/0706:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
2024/1/2922:00GLOBEMadrigal Pharmaceuticals Announces Additions to Its..
2024/1/2608:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2607:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2607:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2605:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2605:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2605:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2222:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
2024/1/1903:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1903:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..